Naltrexone, Naloxone, Morphine, and Fentanyl Pharmacologically Chaperone a Mutant μ-Opioid Receptor via an Endoplasmic Reticulum Exit Site-Dependent Pathway.

Grant SN, Mulcahy MJ, Lester HA

Open source

DOI
10.1002/prp2.70315
Published
2026 Oct
Container
Pharmacology research & perspectives
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/prp2.70315,
  title = {Naltrexone, Naloxone, Morphine, and Fentanyl Pharmacologically Chaperone a Mutant μ-Opioid Receptor via an Endoplasmic Reticulum Exit Site-Dependent Pathway.},
  author = {Grant SN and Mulcahy MJ and Lester HA},
  year = {2026},
  journal = {Pharmacology research \& perspectives},
  doi = {10.1002/prp2.70315},
  url = {https://doi.org/10.1002/prp2.70315}
}

RIS

TY  - JOUR
TI  - Naltrexone, Naloxone, Morphine, and Fentanyl Pharmacologically Chaperone a Mutant μ-Opioid Receptor via an Endoplasmic Reticulum Exit Site-Dependent Pathway.
AU  - Grant SN
AU  - Mulcahy MJ
AU  - Lester HA
PY  - 2026
JO  - Pharmacology research & perspectives
DO  - 10.1002/prp2.70315
UR  - https://doi.org/10.1002/prp2.70315
ER  - 

APA

SN, G., MJ, M., & HA, L. (2026). Naltrexone, Naloxone, Morphine, and Fentanyl Pharmacologically Chaperone a Mutant μ-Opioid Receptor via an Endoplasmic Reticulum Exit Site-Dependent Pathway.. Pharmacology research & perspectives. https://doi.org/10.1002/prp2.70315

Source records